We are much obliged to the Board of Trustees of the Israel Cancer Research Fund (ICRF) for voting to fund our application entitled, “Minimal Transcriptional Archetypes of Drug-Resistance in ER+ Metastatic Breast Cancer.”
We are much obliged to the Board of Trustees of the Israel Cancer Research Fund (ICRF) for voting to fund our application entitled, “Minimal Transcriptional Archetypes of Drug-Resistance in ER+ Metastatic Breast Cancer.”
Leave a Reply